U.S. Markets open in 9 hrs 11 mins

Where Amgen’s Enbrel and Nplate Stand after 2Q17

Daniel Collins

In 2Q17, Amgen’s (AMGN) Enbrel generated revenues of ~$1.5 billion, which represented a ~1% year-over-year decline and a ~24% quarter-over-quarter rise.